Payments to Acquire Property, Plant, and Equipment of Poseida Therapeutics, Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Poseida Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • Poseida Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $130,000, a 83% decline year-over-year.
  • Poseida Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3,066,000, a 22% decline from 2022.
  • Poseida Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $3,924,000, a 49% increase from 2021.
  • Poseida Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $2,634,000, a 84% decline from 2020.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Poseida Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $130,000 -$654,000 -83% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q1 2023 $784,000 +$41,000 +5.5% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $743,000 +$268,000 +56% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $475,000 -$3,041,000 -86% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $3,516,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1

Poseida Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,066,000 -$858,000 -22% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
2022 $3,924,000 +$1,290,000 +49% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $2,634,000 -$14,274,000 -84% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $16,908,000 +$11,752,000 +228% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $5,156,000 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.